This impacts upon on a wide range of stakeholders including: consumers – who now have a wider range of sources of nicotine;researchers – a new research agenda and new methods for studying the use of nicotine containing products; public health and tobacco control advisors – the role of these products within the landscape of smoking reduction and improved public health; parliamentarians and policy makers - faced with developing and monitoring regulatory frameworks;manufacturers and distributors – developing new products, or whose business model is challenged by disruptive products; andnational and international tobacco control organisations – concerned with population level implications for public health and well-being.
Who is this conference is for?
A key feature of the conference is that it is open to all stakeholders – scientists, researchers, policymakers, regulators, parliamentarians, public health, consumers, and companies. There will be two sessions in Polish.
Conference topics will include:
- Scientific understanding of nicotine dependence
- National and international regulation of nicotine products
- New science agenda for nicotine
- Scandinavian experience with snus
- Consumer preferences and views on nicotine products
- Safety and efficacy of electronic cigarettes
- Regulation in Europe - Tobacco Products Directive
- The future of nicotine and tobacco
- WHO, FCTC and FDA
- Acute and long term nicotine toxicity
- Future evolution of nicotine delivery
- Nicotine pharmacology and pharmacokinetics
- Impact on smoking
- Economics of new products
- Public, healthcare professional views
Satellites – Late breaking science; Science update (in Polish); Setting product standards; European consumers’ meeting
Keynote : The Michael Russell Oration - Nicotine science and the public health
Plenaries : A fresh look at alternatives to smoking - the case for reduced risk nicotine products; Overview of the scientific evidence on nicotine: safety, health and addiction; Regulation of non-combustible nicotine products
Parallel sessions : Regulatory landscapes; New science agenda; Future nicotine delivery systems; Public health, politicians and the public (in Polish); Engaging health professionals; What helps smokers switch?
More details on the programme can be found here.
Confirmed speakers to date
Prof Riccardo Polosa (Italy); Dr Konstantinos Farsalinos (Greece); Dr Maciej Goniewicz (USA); Prof Andrzej Sobczak (Poland); Dr Lynne Dawkins (UK); Prof Gerry Stimson (UK); Prof Peter Hajek (UK); Prof Karl Lund (Norway); Hazel Mabe (Germany); Robert Mrówczyński (Poland); Cynthia Cabrera (USA); Dr Mirosław Dworniczak (Poland); Dr Delon Human (Switzerland); Leon Kosmider (Poland); Lou Ritter (USA); Dr Jacques le Houezec (France); Dr Karl Fagerström (Sweden); Clive Bates (UK); Charles Hamshaw-Thomas (UK); Rebecca Taylor, MEP (UK); Lars Ramström (Sweden)
Submit a science poster abstract
Abstracts are invited on any aspect of nicotine science including laboratory, consumer and population studies. Science poster displays will be displayed in the main conference networking area. All accepted posters will be published on the conference legacy website.
If you wish to submit a science poster, please use the conference registration and submission system here.
The conference will be held in the Marriott Hotel in the heart of Warsaw, with good links to international, regional and local transport.
Please visit the conference website www.gfn.net.co for more information and for registration details.